PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB
- 12 August 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (33), 13516-13521
- https://doi.org/10.1073/pnas.1311784110
Abstract
The ubiquitous inducible transcription factor NF-kappa B plays central roles in immune and inflammatory responses and in tumorigenesis. Complex posttranslational modifications of the p65 subunit (RelA) are a major aspect of the extremely flexible regulation of NF-kappa B activity. Although phosphorylation, acetylation, ubiquitination, and lysine methylation of NF-kappa B have been well described, arginine methylation has not yet been found. We now report that, in response to IL-1 beta, the p65 subunit of NF-kappa B is dimethylated on arginine 30 (R30) by protein-arginine methyltransferase 5 (PRMT5). Expression of the R30A and R30K mutants of p65 substantially decreased the ability of NF-kappa B to bind to kappa B elements and to drive gene expression. A model in which dimethyl R30 is placed into the crystal structure of p65 predicts new van der Waals contacts that stabilize intraprotein interactions and indirectly increase the affinity of p65 for DNA. PRMT5 was the only arginine methyltransferase that coprecipitated with p65, and its overexpression increased NF-kappa B activity, whereas PRMT5 knockdown had the opposite effect. Microarray analysis revealed that similar to 85% of the NF-kappa B-inducible genes that are down-regulated by the R30A mutation are similarly down-regulated by knocking PRMT5 down. Many cytokine and chemokine genes are among these, and conditioned media from cells expressing the R30A mutant of p65 had much less NF-kappa B-inducing activity than media from cells expressing the wild-type protein. PRMT5 is overexpressed in many types of cancer, often to a striking degree, indicating that high levels of this enzyme may promote tumorigenesis, at least in part by facilitating NF-kappa B-induced gene expression.Keywords
This publication has 38 references indexed in Scilit:
- Lysine methylation of promoter-bound transcription factors and relevance to cancerCell Research, 2010
- Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signalingNature Immunology, 2010
- Reversible methylation of promoter-bound STAT3 by histone-modifying enzymesProceedings of the National Academy of Sciences of the United States of America, 2010
- Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 MethyltransferaseCancer Cell, 2010
- Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65Proceedings of the National Academy of Sciences of the United States of America, 2009
- Regulation of NF-κB activity through lysine monomethylation of p65Proceedings of the National Academy of Sciences of the United States of America, 2009
- Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFκBProceedings of the National Academy of Sciences of the United States of America, 2009
- Negative regulation of NF-κB action by Set9-mediated lysine methylation of the RelA subunitThe EMBO Journal, 2009
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- Integrating cell-signalling pathways with NF-κB and IKK functionNature Reviews Molecular Cell Biology, 2007